Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-384.3%
operating margin TTM
-411.9%
revenue TTM
1.46 Million
revenue per share TTM
0.02$
valuation ratios | |
|---|---|
| pe ratio | -3.35 |
| peg ratio | 0.09 |
| price to book ratio | 20.74 |
| price to sales ratio | 13.00 |
| enterprise value multiple | -3.59 |
| price fair value | 20.74 |
profitability ratios | |
|---|---|
| gross profit margin | 94.73% |
| operating profit margin | -411.9% |
| pretax profit margin | -384.19% |
| net profit margin | -384.3% |
| return on assets | -50.49% |
| return on equity | -207.18% |
| return on capital employed | -67.74% |
liquidity ratios | |
|---|---|
| current ratio | 4.73 |
| quick ratio | 4.71 |
| cash ratio | 0.59 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 222.75 |
| operating cycle | 267.39 |
| days of payables outstanding | 214.41 |
| cash conversion cycle | 52.98 |
| receivables turnover | 8.18 |
| payables turnover | 1.70 |
| inventory turnover | 1.64 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.04 |
| debt equity ratio | 0.50 |
| long term debt to capitalization | 0.10 |
| total debt to capitalization | 0.34 |
| interest coverage | -224.01 |
| cash flow to debt ratio | -4.57 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.32 |
| cash per share | 5.84 |
| operating cash flow per share | -1.26 |
| free cash flow operating cash flow ratio | 1.05 |
| cash flow coverage ratios | -4.57 |
| short term coverage ratios | -26.50 |
| capital expenditure coverage ratio | -19.70 |
Frequently Asked Questions
When was the last time Kura Oncology, Inc. (NASDAQ:KURA) reported earnings?
Kura Oncology, Inc. (KURA) published its most recent earnings results on 12-08-2026.
What is Kura Oncology, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Kura Oncology, Inc. (NASDAQ:KURA)'s trailing twelve months ROE is -207.18%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Kura Oncology, Inc. (KURA) currently has a ROA of -50.49%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did KURA's net profit margin stand at?
KURA reported a profit margin of -384.3% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is KURA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.73 in the most recent quarter. The quick ratio stood at 4.71, with a Debt/Eq ratio of 0.50.